# Assessment of the Pharmacodynamic and Pharmacokinetic Interaction of Remimazolam and Remifentanil

> **NCT04670471** · PHASE1 · COMPLETED · sponsor: **Paion UK Ltd.** · enrollment: 28 (actual)

## Conditions studied

- Anesthesia

## Interventions

- **DRUG:** Remimazolam
- **DRUG:** Remifentanil

## Key facts

- **NCT ID:** NCT04670471
- **Lead sponsor:** Paion UK Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-13
- **Primary completion:** 2022-01-28
- **Final completion:** 2022-01-28
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2023-09-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04670471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04670471, "Assessment of the Pharmacodynamic and Pharmacokinetic Interaction of Remimazolam and Remifentanil". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04670471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*